Moreover, NO reduction with a highly-selective NOS inhibitor, NG-monomethyl-L-arginine monoacetate (LNMMA), enhanced the radiosensitization of non-small cell lung cancer (NSCLC) cells 21. The gene discussed is NOS1; the disease is non-small cell lung carcinoma.